Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient’s damaged tissues or organs using their own cells. Please use the links to the right to visit our product websites.

NASDAQ: VCEL

$9.17 -0.07 (-0.76%)
Day High: $9.52
Day Low: $8.935
Volume: 670125
4:00 PM on
March 31, 2020
Copyright West LLC. Minimum 15 minutes delayed.

Company Presentation